Início/CVS

Public research page

Market data comes from the live feed. The company research below uses verified public sources, but it is not a real-time personalized AI conclusion.

Analyze CVS in workspace
CVSNYSE/health care

CVS Health Corporation

$105.90Up+1,75 (+1,68%)
Research reviewed: 12 de jul. de 2026, 00:00 UTC
Research overview3-month price contextInvestment thesisKey catalystsLatest earnings researchRecent newsData and research sources

Research overview

CVS Health Corporation operates in Health Care Services within the health care sector. This profile tracks its company-specific earnings drivers, valuation conditions, and primary-source risks.

Открытие
105,00
Максимум
106,40
Минимум
104,62
Капитализация
135,12 млрд
P/E
46.45
Максимум за 52 недели
--
Дивиденд
2.550%
Квартальный дивиденд
--

3-month price context

O gráfico mostra a tendência recente de 3 meses para ajudar usuários a entender a estrutura de curto prazo antes de abrir o workspace completo de pesquisa.

Investment thesis

Base case
Pricing, benefit redesign and membership actions can improve alignment between premiums and medical costs. The base case remains conditional on medical-cost trend staying manageable.
Bull case
Pricing, benefit redesign and membership actions can improve alignment between premiums and medical costs. Insurance, PBM, pharmacy and care-delivery assets can coordinate access and lower total care costs. Retail and specialty pharmacy scale can support purchasing economics and recurring prescription relationships.
Bear case
Higher utilization or acuity can outpace pricing and pressure insurance margins. Rebate, transparency and pharmacy-reimbursement reforms could alter Caremark economics. Leverage and complexity across acquired care assets can limit capital flexibility and delay returns.
Thesis invalidation
Reassess the thesis if higher utilization or acuity can outpace pricing and pressure insurance margins.

Key catalysts

  • Aetna margin recovery

    Pricing, benefit redesign and membership actions can improve alignment between premiums and medical costs.

  • Integrated care model

    Insurance, PBM, pharmacy and care-delivery assets can coordinate access and lower total care costs.

  • Pharmacy scale

    Retail and specialty pharmacy scale can support purchasing economics and recurring prescription relationships.

Principal risks

  • Medical-cost trend

    Higher utilization or acuity can outpace pricing and pressure insurance margins.

  • PBM regulation

    Rebate, transparency and pharmacy-reimbursement reforms could alter Caremark economics.

  • Debt and execution

    Leverage and complexity across acquired care assets can limit capital flexibility and delay returns.

Latest earnings research

Q1 2026

CVS Health's first-quarter 2026 update reflected progress in the Aetna insurance recovery, continued pharmacy and PBM scale and an ongoing effort to simplify health-services operations while managing elevated medical costs.

Valuation interpretation

  • A recovery interpretation depends on sustained insurance repricing rather than a short-lived moderation in medical utilization.
  • Integrated-health optionality should be balanced against PBM policy risk, leverage and operational complexity.

Peer research

ABBVJNJLLY

Recent news

Trefis · 8 часов назад

The Premium On CVS Stock Vs What Its Peers Deliver

Zacks · 9 часов назад

Humana Eyes 3% Medicare Advantage Margin: Can It Deliver?

Insider Monkey · 10 часов назад

Jim Cramer Says “Buy the Stock of CVS, I Sure Wish I’d Done It for My Trust”

Barrons.com · 19 часов назад

Elevance and UnitedHealth Earnings Are Next Test for Hot Health Insurer Stocks

Motley Fool · 3 дня назад

2 Recession-Resistant Dividend Stocks to Buy and Hold

Zacks · 3 дня назад

Brookdale Senior Q2'26 Sneak Peek: Occupancy Volume Rises to 82.4%

Data and research sources

Research updated: 12 de jul. de 2026, 00:00 UTC
3 verified sources
CVS Health Reports First Quarter 2026 ResultsCVS Health Corporation · earningsVerified

Fetched: 12/07/2026, 0:00:00 UTC

Published: 06/05/2026, 00:00:00

Open original source
CVS Health Corporation Investor RelationsCVS Health Corporation · companyVerified

Fetched: 12/07/2026, 0:00:00 UTC

Open original source
CVS Health SEC filings and company factsU.S. Securities and Exchange Commission · filingVerified

Fetched: 12/07/2026, 0:00:00 UTC

Published: 06/05/2026, 00:00:00

Open original source

Continue in the research workspace

Keep CVS in context, run a multi-agent analysis, and monitor thesis changes.

Analyze CVS free

Conheça todo o sistema de análise

Cada etapa tem uma função clara e deixa um resultado auditável.

Metodologia de análiseLer relatórios de mercadoExplorar ações

Continue researching this stock

Analista de Mercado

Analista de Mercado se especializa na etapa de Observar dentro de Pesquisa central e organiza o contexto para os próximos papéis.

Analista Fundamentalista

Analista Fundamentalista se especializa na etapa de Observar dentro de Pesquisa central e organiza o contexto para os próximos papéis.

Analista de Notícias

Analista de Notícias se especializa na etapa de Observar dentro de Pesquisa central e organiza o contexto para os próximos papéis.

Gestor de Risco

Gestor de Risco se especializa na etapa de Monitorar dentro de Risco e monitoramento e organiza o contexto para os próximos papéis.